Small molecules with antimicrobial activity against E. coli and P. aeruginosa identified by high‐throughput screening
- 1 November 2006
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 149 (5), 551-559
- https://doi.org/10.1038/sj.bjp.0706873
Abstract
New antimicrobials are needed because of the emergence of organisms that are resistant to available antimicrobials. The purpose of this study was to evaluate a high-throughput screening approach to identify antibacterials against two common disease-causing bacteria, and to determine the frequency, novelty, and potency of compounds with antibacterial activity. A high-throughput, turbidometric assay of bacterial growth in a 96-well plate format was used to screen a diverse collection of 150,000 small molecules for antibacterial activity against E. coli and P. aeruginosa. The statistical Z'-factor for the assay was > or = 0.7. Screening for inhibition of E. coli growth gave a 'hit' rate (> 60% inhibition at 12.5 microM) of 0.025%, which was more than 5-fold reduced for P. aeruginosa. The most potent antibacterials (EC50 < 0.5 microM) were of the nitrofuran class followed by naphthalimide, salicylanilide, bipyridinium and quinoazolinediamine chemical classes. Screening of > 250 analogs of the most potent antibacterial classes established structure-activity data sets. Our results validate and demonstrate the utility of a growth-based phenotype screen for rapid identification of small-molecule antibacterials. The favourable efficacy and structure-activity data for several of the antibacterial classes suggests their potential development for clinical use.Keywords
This publication has 60 references indexed in Scilit:
- Lack of development of new antimicrobial drugs: a potential serious threat to public healthThe Lancet Infectious Diseases, 2005
- EnteropathogenicEscherichia coli: unravelling pathogenesisFEMS Microbiology Reviews, 2005
- Novel AntibacterialClassAntimicrobial Agents and Chemotherapy, 2003
- Antibacterials: are the new entries enough to deal with the emerging resistance problems?Current Opinion in Biotechnology, 2003
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Editorial - New AntibioticsInternational Journal of Medical Microbiology, 2001
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Synthesis and antimicrobial activity of salicylanilide derivatives. II.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Phenylalanyl transfer ribonucleic acid synthetase from Escherichia coli B. Potent inhibition by analogs of N-benzyl-2-phenylethylamineJournal of Medicinal Chemistry, 1976
- A Rapid Method for the Turbidimetric Assay of AntibioticsJournal of General Microbiology, 1952